Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Capital Expenditures (2020 - 2025)

Sotera Health (SHC) has 6 years of Capital Expenditures data on record, last reported at -$62.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 901.11% year-over-year to -$62.0 million; the TTM value through Dec 2025 reached $25.3 million, up 148.82%, while the annual FY2025 figure was $25.3 million, 148.82% up from the prior year.
  • Capital Expenditures reached -$62.0 million in Q4 2025 per SHC's latest filing, down from $36.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $85.1 million in Q2 2023 and bottomed at -$133.4 million in Q4 2023.
  • Average Capital Expenditures over 5 years is $12.5 million, with a median of $25.6 million recorded in 2025.
  • Peak YoY movement for Capital Expenditures: soared 257.93% in 2021, then crashed 901.11% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$46.4 million in 2021, then surged by 254.69% to $71.7 million in 2022, then plummeted by 286.0% to -$133.4 million in 2023, then soared by 95.36% to -$6.2 million in 2024, then plummeted by 901.11% to -$62.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$62.0 million in Q4 2025, $36.2 million in Q3 2025, and $31.2 million in Q2 2025.